BI Analyst Briefing: Allergy & Asthma Expert Discussion

Bloomberg Intelligence and inThought Research are hosting an expert discussion to delve into recent clinical data and use of novel agents to treat moderate/severe atopic dermatitis, asthma, allergies etc. We will also aim to dig deep into the mechanisms and merits of IL-4, IL-5, IL-13, IL-33, TSLP, JAK, etc, and reflect on our experts’ use of Dupixent in their practice.

We will also discuss relevant data and use of novel hereditary angioedema agents if time permits.

Guest Speakers:

Expert 1: David Amrol, MD (U South Carolina) Dr. Amrol is the Director of the Division of Allergy and Immunology, and Associate Professor of Clinical Internal Medicine at the University of South Carolina. His academic interests include asthma, allergic rhinitis, atopic dermatitis, food allergy, and immunodeficiency. He is first/last author on more than a dozen peer reviewed journal articles articulating the biology or treatment profile of novel agents for atopic dermatitis, asthma, eosinophilic sinusitis, etc, or discussing environmental triggers. Dr. Amrol treats both children and adults.

Expert 2: Paula Busse, MD (Mt Sinai) Dr. Busse is an Associate Professor in the Department of Medicine, Division of Clinical Immunology, at Mt Sinai. Her clinical and research areas of interest are asthma in older patients and treatment of hereditary angioedema. Dr. Busse is funded by the NIH and several foundation grants, and has served as PI on several HAE trials. She is active in the American Academy of Allergy, Asthma and Immunology, giving lectures at national and local meetings and is involved in several of its committees.

Expert 3: Michael Wechsler, MD (National Jewish Health) Dr. Wechsler is Director of Asthma, and Professor of Medicine at National Jewish Health in Denver. Previously he served as Associate Director of the Brigham and Women’s Hospital Asthma Research Center in Boston. He is a member of the Steering Committee for the NIH’s Asthma Clinical Research Network/Asthmanet. Dr. Wechsler is active in both basic and clinical research focused on asthma and allergies, and his scientific interests include genetics of asthma, Churg-Strauss syndrome, and eosinophilia, with multiple clinical and research manuscripts published in leading medical journals. Dr. Wechsler has received research

Date

Apr 17 2019

Time

10:00 am - 12:00 pm
Category

Organizer

Bloomberg Intelligence

Other Organizers

inThought Research